Lipum – biological drugs against rheumatoid arthritis

The aim of this project is to develop a new and unique biological pharmaceutical drug, targeting a central mechanism in chronic inflammation (a monoclonal antibody directed towards the protein bile salt-stimulated lipase, BSSL) as an orphan drug for the more severe forms of Juvenile Idiopathic Arthritis (JIA), providing patients with an effective treatment alternative and with less adverse effects than the drugs used today.

Read more